2,500 Shares Ovid Therapeutics Inc. Series A Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2019 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 21st, 2019 Company Industry Jurisdiction